AU5503199A - Analytic substrates and antioxidative agents - Google Patents
Analytic substrates and antioxidative agentsInfo
- Publication number
- AU5503199A AU5503199A AU55031/99A AU5503199A AU5503199A AU 5503199 A AU5503199 A AU 5503199A AU 55031/99 A AU55031/99 A AU 55031/99A AU 5503199 A AU5503199 A AU 5503199A AU 5503199 A AU5503199 A AU 5503199A
- Authority
- AU
- Australia
- Prior art keywords
- analytic substrates
- antioxidative agents
- antioxidative
- agents
- analytic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C203/00—Esters of nitric or nitrous acid
- C07C203/02—Esters of nitric acid
- C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
- C07D321/12—Eight-membered rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
- C09K15/06—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Biotechnology (AREA)
- Emergency Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1998127981 DE19827981A1 (en) | 1998-06-24 | 1998-06-24 | New nitrate compounds useful in biochemical or pharmacological studies of e.g. cysteine/cystine system or for studies of nitrate cross-tolerance associated with certain cardiovascular drugs |
DE19830006 | 1998-06-24 | ||
DE19827981 | 1998-06-24 | ||
DE1998130006 DE19830006A1 (en) | 1998-06-24 | 1998-06-24 | New pentaerythritol nitrate derivatives useful for treating cardiovascular disorders etc |
DE19829908 | 1998-07-06 | ||
DE1998129908 DE19829908A1 (en) | 1998-07-06 | 1998-07-06 | Use of known and new pentaerythritol derivatives as analytical substrates and medicaments, e.g. for treatment of cardiovascular disorders |
PCT/DE1999/001834 WO1999067430A2 (en) | 1998-06-24 | 1999-06-24 | Analytic substrates and antioxidative agents |
Publications (1)
Publication Number | Publication Date |
---|---|
AU5503199A true AU5503199A (en) | 2000-01-10 |
Family
ID=27218471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU55031/99A Abandoned AU5503199A (en) | 1998-06-24 | 1999-06-24 | Analytic substrates and antioxidative agents |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1087926A2 (en) |
AU (1) | AU5503199A (en) |
WO (1) | WO1999067430A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19950483A1 (en) * | 1999-10-19 | 2001-05-10 | Isis Pharma Gmbh | Process for the preparation of 3-nitryloxy-2,2-bis (nitryloxymethyl) -propanal |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2275586A (en) * | 1938-03-25 | 1942-03-10 | Gen Aniline & Film Corp | Tri (hydroxy methyl) acetaldehyde and a process of making it |
BE632627A (en) * | 1962-06-07 | |||
US3419571A (en) * | 1966-04-06 | 1968-12-31 | Warner Lambert Pharmaceutical | Method for relieving coronary insufficiency |
DE4410997A1 (en) * | 1994-03-30 | 1995-10-26 | Isis Pharma Gmbh | Pharmaceutical preparations and drugs for the prevention and treatment of endothelial dysfunctions |
EA001959B1 (en) * | 1996-10-10 | 2001-10-22 | Альфарма-Изис Гмбх Унд Ко. Кг | New pentaerythritol derivatives, their production and use and intermediatesfor their synthesis |
ZA989356B (en) * | 1997-10-16 | 1998-11-16 | Isis Pharma Gmbh | Pharmaceutical preparations |
-
1999
- 1999-06-24 AU AU55031/99A patent/AU5503199A/en not_active Abandoned
- 1999-06-24 EP EP99941378A patent/EP1087926A2/en not_active Withdrawn
- 1999-06-24 WO PCT/DE1999/001834 patent/WO1999067430A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999067430A3 (en) | 2000-05-04 |
EP1087926A2 (en) | 2001-04-04 |
WO1999067430A2 (en) | 1999-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3978199A (en) | Multiconfiguration backplane | |
AU9790198A (en) | Compounds and methods | |
AU4208799A (en) | Interleukins-21 and 22 | |
AU7989400A (en) | Compounds and methods | |
AU3215500A (en) | Compounds and methods | |
AU9781998A (en) | Huchordin and uses thereof | |
AU4198299A (en) | Compounds and uses thereof | |
AU2349399A (en) | R-lansoprazole compositions and methods | |
AU3753599A (en) | Micro-compartmentalization device and uses thereof | |
AU5203698A (en) | Fluid-treatment assemblies | |
AUPP433398A0 (en) | Compounds and processes | |
AU9301998A (en) | Composition and methods using galectin-1 | |
AU7094498A (en) | Dummy | |
AU8695298A (en) | Compounds and uses thereof | |
AU1064800A (en) | Products and methods | |
AU2333099A (en) | Aryloxyanilides and related compounds | |
AU6300898A (en) | Well treatment with particles | |
AU5875799A (en) | Mip-1alpha isoform ld78beta and uses thereof | |
AUPO982097A0 (en) | Methods and compositions for use therein | |
AU3086200A (en) | Eyesight-correction and/or eye-training device | |
AU5979300A (en) | Angiopoietin-6 and uses thereof | |
AU5503199A (en) | Analytic substrates and antioxidative agents | |
AU8693198A (en) | Compounds and uses thereof | |
AU5386498A (en) | Enhancement phalloplasty | |
AU3900499A (en) | (+)-hydroxyrisperidone compositions and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |